盈康生命：前三季度营收净利双增 发展韧性凸显

Core Insights - The company reported a revenue of 1.358 billion yuan for the first three quarters of 2025, marking a year-on-year growth of 10.59% [1] - The net profit attributable to shareholders reached 86.839 million yuan, with a year-on-year increase of 5.2% [1] - The non-recurring net profit attributable to shareholders was 85.431 million yuan, reflecting a year-on-year growth of 12.53% [1] Financial Performance - The operating cash flow has shown continuous improvement throughout the year, with net cash flow from operating activities reaching 68.68 million yuan in Q1, 79.94 million yuan in Q2 (a quarter-on-quarter growth of over 16.4%), and 99.11 million yuan in Q3 (a quarter-on-quarter growth of 23.97%) [1] - The stable cash flow provides a solid financial foundation for the company's future development [1] Strategic Focus - The integration of "Healthcare + AI" is a core strategy for the company, driving high-quality development [2] - The company aims to reshape the entire medical service chain through AI, enhancing capabilities, efficiency, and patient experience [2] - The company is positioned favorably in the healthcare industry, leveraging AI technology to maintain profitability and growth amid increasing differentiation in the private healthcare sector [2]